Cart
sales@molnova.com
beta-Glucogallin
CAS No. 13405-60-2
beta-Glucogallin( —— )
Catalog No. M33086 CAS No. 13405-60-2
beta-Glucogallin (beta-Glucogallin) is a selective aldose reductase (AKR1B1) inhibitor with antioxidant, anti-glycation, and anti-inflammatory properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 85 | In Stock |
|
| 5MG | 121 | In Stock |
|
| 10MG | 176 | In Stock |
|
| 25MG | 389 | In Stock |
|
| 50MG | 674 | In Stock |
|
| 100MG | 1233 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namebeta-Glucogallin
-
NoteResearch use only, not for human use.
-
Brief Descriptionbeta-Glucogallin (beta-Glucogallin) is a selective aldose reductase (AKR1B1) inhibitor with antioxidant, anti-glycation, and anti-inflammatory properties.
-
Descriptionβ-Glucogallin is a potent and selective aldose reductase (AKR1B1) inhibitor. β-Glucogallin can be isolated from the medicinal plant Emblica officinalis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetReductase
-
RecptorReductase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number13405-60-2
-
Formula Weight332.26
-
Molecular FormulaC13H16O10
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO(C(=O)C1=CC(O)=C(O)C(O)=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Li L, et al. Design of an amide N-glycoside derivative of β-glucogallin: a stable, potent, and specific inhibitor of aldose reductase. J Med Chem. 2014 Jan 9;57(1):71-7.?
molnova catalog
related products
-
Sulindac sulfone
Sulindac sulfone is a metabolite of the nonsteroidal anti-inflammatory drug sulindac. Sulindac sulfone is an inhibitor of aldose reductase (IC50 =367 nM).
-
VU 0364770
VU 0364770(EC50=1.1 μM), a positive allosteric modulator(PAM) of mGlu4, shows insignificant activity at 68 other receptors, including other mGlu subtypes.
-
WJ-39
WJ-39 is an orally active aldose reductase (AR) inhibitor that ameliorates renal lesions in diabetic nephropathy through activation of Nrf2 signaling, and may be used to ameliorate renal insufficiency and fibrosis.
